|
Curb, Alter, Lower, or Manage Stress in HIV: CALMS-HIV Clinical Trials Information presented on Clinical Trials Search is not designed to be a substitute for proven healthcare advice, travels to or treatment by using a genuine medical doctor. We are not physicians. Always confer with your doctor on Curb, Alter, Lower, or Manage Stress in HIV: CALMS-HIV conditions. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. Curb, Alter, Lower, or Manage Stress in HIV: CALMS-HIV Clinical research trials and Curb, Alter, Lower, or Manage Stress in HIV: CALMS-HIV healthcare trials take place in many of cities across the United States of America. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally evaluate the effectiveness of new drugs. The function of the studies / undertakings is to answer specific human medical questions. Clinical trials are a popular means for mDs, government agencies, and private sector companies to find treatments for all forms of conditions, including Curb, Alter, Lower, or Manage Stress in HIV: CALMS-HIV. Curb, Alter, Lower, or Manage Stress in HIV: CALMS-HIV Clinical Trials and other clinical trials allow for volunteers to access medical treatment alternatives before they are available to the masses. Many times the test subjects undergo treatment for without cost, and occasionally they are compensated for their time. Occasionally there is a cost for a Curb, Alter, Lower, or Manage Stress in HIV: CALMS-HIV clinical trial. Test subjects oftentimes recieve the best healthcare possible for their Curb, Alter, Lower, or Manage Stress in HIV: CALMS-HIV condition. Hazards are a reality, nonetheless, and might include additional or frequent doctor trips, healthcare hazards (perhaps life-jeopardizing), and/or the treatment being ineffective. Trials are federally regulated with rigid guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "C" Clinical Trials Conditions > Curb, Alter, Lower, or Manage Stress in HIV: CALMS-HIV  Curb, Alter, Lower, or Manage Stress in HIV: CALMS-HIV
Curb, Alter, Lower, or Manage Stress in HIV: CALMS-HIV
For Condition: HIV Infections
Status: Recruiting
Sponsor(s): National Center for Complementary and Alternative Medicine (NCCAM) ,
Synopsis: The purpose of this study is to determine the efficacy of a stress management group intervention for people with HIV. The study will evaluate several outcomes, including perceived stress, quality of life, psychosocial factors, and physiological measures of stress.
Details: It is well documented that living with HIV/AIDS is stressful, and evidence suggests that stress may hasten HIV disease progression by increasing viral replication and suppressing the immune response. Stress management intervention studies using more complex combinations of cognitive and relaxation therapies have shown improvements in both psychological and physiological measures in HIV infected persons. However, no studies have focused on only one intervention or have addressed the spiritual component using a comparable control group to determine which of these interventions is most effective. A randomized trial will be conducted to compare a spiritually based cognitive intervention to an educational control group. The intervention will be given over a 10-week period, with 5 weekly classes, 4 weekly automated phone calls, and one final class meeting. Assessments will be conducted at pre-intervention, fifth class midpoint, tenth week post-intervention, and 3-month follow-up. Time commitment can vary from 6 months to 9 months, depending on when the patient is screened.
Eligibility:
Study Type: Interventional, Educational/Counseling/Training, Randomized, Single Blind, Active Control, Parallel Assignment, Efficacy Study
Minimum Age/Maximum Age: 18 Years/65 Years
Genders: Both
Protocol Entry Criteria: Inclusion Criteria: - HIV infected for at least 6 months - Ability to read and write English Exclusion Criteria: - Drug use within the past 6 months - Cognitive impairment or dementia - Diagnosis that may affect cortisol levels, such as diabetes, cancer, or asthma - Loss of family/loved one in past 3 months - Started a relaxation therapy in past 3 months - History or current practice of the RISE program, rosary, chanting, or Transcendental Meditation (TM) - Acute infection in past month - Change of HAART or drug regimen in past month
Total Enrollment: 60
Location and Contact Information:
VA San Diego Healthcare System *Recruiting*
San Diego, California, 92116
United States
Recruiting Pat Bone 858-552-8585
Additional Information:
Study ID Numbers: 1 R21 AT01159-01A1;
Study Start Date: May 2003
Record last reviewed: October 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00057538
Other Hiv Infections Studies:
1. A Phase I Study of the Safety and Pharmacokinetics of Recombinant Human CD4 Immunoglobulin (rCd4-IgG) Administered by Intravenous Bolus in Patients With AIDS and AIDS Related Complex
2. Problems Associated with the Use of Anti-HIV Drugs in HIV-Infected Pregnant Women
3. SCH 39304 as Therapy for Acute Cryptococcal Meningitis in HIV-Infected Patients Followed by Maintenance Therapy
4. A Study of Two Anti-HIV Drug Combinations
5. HIV Incidence and Participation Retention in Pune, India
Related Studies:
Other HIV Infections Clinical Trials
Other California Clinical Trials
Other San Diego Clinical Trials
Curb, Alter, Lower, or Manage Stress in HIV: CALMS-HIV
|
|
|
|
|
|
|
|
